nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—PTGS2—Triamcinolone—psoriasis	0.225	0.424	CbGbCtD
Nepafenac—PTGS2—Betamethasone—psoriasis	0.193	0.364	CbGbCtD
Nepafenac—PTGS2—Dexamethasone—psoriasis	0.112	0.212	CbGbCtD
Nepafenac—PTGS2—skeletal joint—psoriasis	0.00938	0.285	CbGeAlD
Nepafenac—PTGS2—synovial membrane of synovial joint—psoriasis	0.00712	0.216	CbGeAlD
Nepafenac—PTGS2—skin epidermis—psoriasis	0.00457	0.139	CbGeAlD
Nepafenac—PTGS1—endothelium—psoriasis	0.00347	0.105	CbGeAlD
Nepafenac—PTGS2—endothelium—psoriasis	0.00332	0.101	CbGeAlD
Nepafenac—Impaired healing—Betamethasone—psoriasis	0.00195	0.00462	CcSEcCtD
Nepafenac—PTGS2—Fluocinonide—Clobetasol propionate—psoriasis	0.00195	0.157	CbGdCrCtD
Nepafenac—Dry eye—Acitretin—psoriasis	0.00193	0.00457	CcSEcCtD
Nepafenac—Dry eye—Fluocinolone Acetonide—psoriasis	0.00193	0.00456	CcSEcCtD
Nepafenac—Intraocular pressure increased—Betamethasone—psoriasis	0.00192	0.00455	CcSEcCtD
Nepafenac—Conjunctival hyperaemia—Dexamethasone—psoriasis	0.00192	0.00455	CcSEcCtD
Nepafenac—Conjunctival hyperaemia—Betamethasone—psoriasis	0.00192	0.00455	CcSEcCtD
Nepafenac—Intraocular pressure increased—Dexamethasone—psoriasis	0.00192	0.00455	CcSEcCtD
Nepafenac—Endophthalmitis—Dexamethasone—psoriasis	0.00177	0.0042	CcSEcCtD
Nepafenac—Endophthalmitis—Betamethasone—psoriasis	0.00177	0.0042	CcSEcCtD
Nepafenac—Sinusitis—Beclomethasone—psoriasis	0.00177	0.00419	CcSEcCtD
Nepafenac—Blepharitis—Mycophenolate mofetil—psoriasis	0.00176	0.00418	CcSEcCtD
Nepafenac—Diabetes mellitus—Acitretin—psoriasis	0.00175	0.00413	CcSEcCtD
Nepafenac—Impaired healing—Prednisone—psoriasis	0.0017	0.00403	CcSEcCtD
Nepafenac—Eye pain—Acitretin—psoriasis	0.00168	0.00398	CcSEcCtD
Nepafenac—Eye pain—Fluocinolone Acetonide—psoriasis	0.00168	0.00397	CcSEcCtD
Nepafenac—Keratitis—Mycophenolate mofetil—psoriasis	0.00167	0.00396	CcSEcCtD
Nepafenac—Intraocular pressure increased—Prednisone—psoriasis	0.00167	0.00396	CcSEcCtD
Nepafenac—Arthritis—Acitretin—psoriasis	0.00156	0.0037	CcSEcCtD
Nepafenac—Keratitis—Prednisolone—psoriasis	0.00156	0.00369	CcSEcCtD
Nepafenac—PTGS2—Fluocinonide—Beclomethasone—psoriasis	0.00156	0.126	CbGdCrCtD
Nepafenac—Hypersensitivity—Calcipotriol—psoriasis	0.00156	0.00369	CcSEcCtD
Nepafenac—Endophthalmitis—Prednisone—psoriasis	0.00155	0.00366	CcSEcCtD
Nepafenac—PTGS2—Fluocinonide—Fluocinolone Acetonide—psoriasis	0.00152	0.122	CbGdCrCtD
Nepafenac—Immune system disorder—Fluocinonide—psoriasis	0.00152	0.00359	CcSEcCtD
Nepafenac—Pruritus—Calcipotriol—psoriasis	0.0015	0.00354	CcSEcCtD
Nepafenac—PTGS1—skin of body—psoriasis	0.00148	0.0449	CbGeAlD
Nepafenac—Cataract—Mycophenolic acid—psoriasis	0.00144	0.00342	CcSEcCtD
Nepafenac—Diclofenac—CXCL8—psoriasis	0.00144	0.53	CrCbGaD
Nepafenac—Impaired healing—Methotrexate—psoriasis	0.00142	0.00336	CcSEcCtD
Nepafenac—Visual acuity reduced—Betamethasone—psoriasis	0.00142	0.00336	CcSEcCtD
Nepafenac—Visual acuity reduced—Dexamethasone—psoriasis	0.00142	0.00336	CcSEcCtD
Nepafenac—PTGS2—skin of body—psoriasis	0.00142	0.043	CbGeAlD
Nepafenac—Blood pressure increased—Mycophenolic acid—psoriasis	0.00138	0.00326	CcSEcCtD
Nepafenac—Blepharitis—Betamethasone—psoriasis	0.00137	0.00325	CcSEcCtD
Nepafenac—Blepharitis—Dexamethasone—psoriasis	0.00137	0.00325	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Clobetasol propionate—psoriasis	0.00137	0.00324	CcSEcCtD
Nepafenac—Dermatitis atopic—Prednisolone—psoriasis	0.00137	0.00324	CcSEcCtD
Nepafenac—Keratitis—Betamethasone—psoriasis	0.0013	0.00308	CcSEcCtD
Nepafenac—Keratitis—Dexamethasone—psoriasis	0.0013	0.00308	CcSEcCtD
Nepafenac—Skin disorder—Clobetasol propionate—psoriasis	0.00128	0.00304	CcSEcCtD
Nepafenac—Ketoprofen—CXCL8—psoriasis	0.00128	0.47	CrCbGaD
Nepafenac—Dermatitis atopic—Triamcinolone—psoriasis	0.00126	0.00298	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Fluocinonide—psoriasis	0.00124	0.00292	CcSEcCtD
Nepafenac—Lacrimation increased—Cyclosporine—psoriasis	0.00121	0.00286	CcSEcCtD
Nepafenac—Eye irritation—Prednisolone—psoriasis	0.00119	0.00281	CcSEcCtD
Nepafenac—PTGS2—Fluticasone Propionate—Clobetasol propionate—psoriasis	0.00118	0.0949	CbGdCrCtD
Nepafenac—Nervous system disorder—Fluocinonide—psoriasis	0.00117	0.00277	CcSEcCtD
Nepafenac—Cataract—Cyclosporine—psoriasis	0.00117	0.00277	CcSEcCtD
Nepafenac—Skin disorder—Fluocinonide—psoriasis	0.00116	0.00274	CcSEcCtD
Nepafenac—Diabetes mellitus—Mycophenolic acid—psoriasis	0.00115	0.00272	CcSEcCtD
Nepafenac—Cataract—Mycophenolate mofetil—psoriasis	0.00114	0.0027	CcSEcCtD
Nepafenac—PTGS1—tendon—psoriasis	0.00113	0.0342	CbGeAlD
Nepafenac—Pruritus—Tazarotene—psoriasis	0.0011	0.00261	CcSEcCtD
Nepafenac—Sinusitis—Acitretin—psoriasis	0.0011	0.0026	CcSEcCtD
Nepafenac—Sinusitis—Fluocinolone Acetonide—psoriasis	0.00109	0.00259	CcSEcCtD
Nepafenac—PTGS2—tendon—psoriasis	0.00108	0.0327	CbGeAlD
Nepafenac—Cataract—Hydrocortisone—psoriasis	0.00104	0.00246	CcSEcCtD
Nepafenac—Arthritis—Mycophenolic acid—psoriasis	0.00103	0.00243	CcSEcCtD
Nepafenac—Photophobia—Mycophenolate mofetil—psoriasis	0.00102	0.00241	CcSEcCtD
Nepafenac—Dermatitis atopic—Prednisone—psoriasis	0.000994	0.00235	CcSEcCtD
Nepafenac—Eye disorder—Acitretin—psoriasis	0.000981	0.00232	CcSEcCtD
Nepafenac—Eye disorder—Fluocinolone Acetonide—psoriasis	0.000979	0.00232	CcSEcCtD
Nepafenac—Cataract—Triamcinolone—psoriasis	0.000978	0.00231	CcSEcCtD
Nepafenac—Hypersensitivity—Clobetasol propionate—psoriasis	0.000974	0.0023	CcSEcCtD
Nepafenac—Angiopathy—Acitretin—psoriasis	0.000953	0.00226	CcSEcCtD
Nepafenac—Immune system disorder—Acitretin—psoriasis	0.000949	0.00225	CcSEcCtD
Nepafenac—PTGS2—Fluticasone Propionate—Fluocinonide—psoriasis	0.000941	0.076	CbGdCrCtD
Nepafenac—PTGS2—Fluticasone Propionate—Beclomethasone—psoriasis	0.000941	0.076	CbGdCrCtD
Nepafenac—Pruritus—Clobetasol propionate—psoriasis	0.000935	0.00221	CcSEcCtD
Nepafenac—Diabetes mellitus—Cyclosporine—psoriasis	0.000928	0.0022	CcSEcCtD
Nepafenac—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	0.000915	0.0738	CbGdCrCtD
Nepafenac—Skin disorder—Methoxsalen—psoriasis	0.000914	0.00216	CcSEcCtD
Nepafenac—Dry eye—Hydrocortisone—psoriasis	0.000913	0.00216	CcSEcCtD
Nepafenac—Diabetes mellitus—Mycophenolate mofetil—psoriasis	0.000906	0.00214	CcSEcCtD
Nepafenac—Eye pain—Cyclosporine—psoriasis	0.000895	0.00212	CcSEcCtD
Nepafenac—Cataract—Betamethasone—psoriasis	0.000887	0.0021	CcSEcCtD
Nepafenac—Cataract—Dexamethasone—psoriasis	0.000887	0.0021	CcSEcCtD
Nepafenac—Hypertension—Calcitriol—psoriasis	0.000887	0.0021	CcSEcCtD
Nepafenac—Hypersensitivity—Fluocinonide—psoriasis	0.000878	0.00208	CcSEcCtD
Nepafenac—Eye pain—Mycophenolate mofetil—psoriasis	0.000873	0.00207	CcSEcCtD
Nepafenac—Vision blurred—Acitretin—psoriasis	0.000862	0.00204	CcSEcCtD
Nepafenac—Vision blurred—Fluocinolone Acetonide—psoriasis	0.000859	0.00203	CcSEcCtD
Nepafenac—Dry mouth—Calcitriol—psoriasis	0.000856	0.00203	CcSEcCtD
Nepafenac—Diabetes mellitus—Prednisolone—psoriasis	0.000845	0.002	CcSEcCtD
Nepafenac—Pruritus—Fluocinonide—psoriasis	0.000843	0.002	CcSEcCtD
Nepafenac—Arthritis—Cyclosporine—psoriasis	0.000831	0.00197	CcSEcCtD
Nepafenac—Headache—Clobetasol propionate—psoriasis	0.000828	0.00196	CcSEcCtD
Nepafenac—Diabetes mellitus—Hydrocortisone—psoriasis	0.000825	0.00195	CcSEcCtD
Nepafenac—Skin disorder—Calcitriol—psoriasis	0.000815	0.00193	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Methoxsalen—psoriasis	0.000812	0.00192	CcSEcCtD
Nepafenac—Dizziness—Beclomethasone—psoriasis	0.000796	0.00188	CcSEcCtD
Nepafenac—Dizziness—Fluocinonide—psoriasis	0.000788	0.00187	CcSEcCtD
Nepafenac—Dry eye—Dexamethasone—psoriasis	0.00078	0.00185	CcSEcCtD
Nepafenac—Dry eye—Betamethasone—psoriasis	0.00078	0.00185	CcSEcCtD
Nepafenac—Diabetes mellitus—Triamcinolone—psoriasis	0.000777	0.00184	CcSEcCtD
Nepafenac—Cataract—Prednisone—psoriasis	0.000773	0.00183	CcSEcCtD
Nepafenac—Dry mouth—Acitretin—psoriasis	0.000761	0.0018	CcSEcCtD
Nepafenac—Headache—Beclomethasone—psoriasis	0.000754	0.00178	CcSEcCtD
Nepafenac—Angiopathy—Hydroxyurea—psoriasis	0.000748	0.00177	CcSEcCtD
Nepafenac—Headache—Fluocinonide—psoriasis	0.000747	0.00177	CcSEcCtD
Nepafenac—Nervous system disorder—Fluocinolone Acetonide—psoriasis	0.00073	0.00173	CcSEcCtD
Nepafenac—Skin disorder—Acitretin—psoriasis	0.000725	0.00172	CcSEcCtD
Nepafenac—Sinusitis—Mycophenolic acid—psoriasis	0.000722	0.00171	CcSEcCtD
Nepafenac—Nausea—Beclomethasone—psoriasis	0.000715	0.00169	CcSEcCtD
Nepafenac—PTGS2—Fluocinonide—Betamethasone—psoriasis	0.000711	0.0574	CbGdCrCtD
Nepafenac—PTGS2—Fluocinonide—Dexamethasone—psoriasis	0.000711	0.0574	CbGdCrCtD
Nepafenac—Diabetes mellitus—Dexamethasone—psoriasis	0.000705	0.00167	CcSEcCtD
Nepafenac—Diabetes mellitus—Betamethasone—psoriasis	0.000705	0.00167	CcSEcCtD
Nepafenac—PTGS2—Fluocinonide—Triamcinolone—psoriasis	0.000695	0.0561	CbGdCrCtD
Nepafenac—Hypersensitivity—Methoxsalen—psoriasis	0.000693	0.00164	CcSEcCtD
Nepafenac—Eye pain—Betamethasone—psoriasis	0.000679	0.00161	CcSEcCtD
Nepafenac—Eye pain—Dexamethasone—psoriasis	0.000679	0.00161	CcSEcCtD
Nepafenac—Pruritus—Methoxsalen—psoriasis	0.000666	0.00158	CcSEcCtD
Nepafenac—Eye disorder—Mycophenolic acid—psoriasis	0.000645	0.00153	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Acitretin—psoriasis	0.000644	0.00152	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Fluocinolone Acetonide—psoriasis	0.000642	0.00152	CcSEcCtD
Nepafenac—Angiopathy—Mycophenolic acid—psoriasis	0.000627	0.00148	CcSEcCtD
Nepafenac—Dizziness—Methoxsalen—psoriasis	0.000622	0.00147	CcSEcCtD
Nepafenac—Hypersensitivity—Calcitriol—psoriasis	0.000618	0.00146	CcSEcCtD
Nepafenac—Diabetes mellitus—Prednisone—psoriasis	0.000614	0.00145	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—psoriasis	0.000607	0.00144	CcSEcCtD
Nepafenac—Pruritus—Calcitriol—psoriasis	0.000593	0.0014	CcSEcCtD
Nepafenac—Headache—Methoxsalen—psoriasis	0.000589	0.0014	CcSEcCtD
Nepafenac—Sinusitis—Cyclosporine—psoriasis	0.000584	0.00138	CcSEcCtD
Nepafenac—Nervous system disorder—Hydroxyurea—psoriasis	0.000574	0.00136	CcSEcCtD
Nepafenac—Sinusitis—Mycophenolate mofetil—psoriasis	0.00057	0.00135	CcSEcCtD
Nepafenac—Skin disorder—Hydroxyurea—psoriasis	0.000569	0.00135	CcSEcCtD
Nepafenac—Vision blurred—Mycophenolic acid—psoriasis	0.000567	0.00134	CcSEcCtD
Nepafenac—Nausea—Methoxsalen—psoriasis	0.000559	0.00132	CcSEcCtD
Nepafenac—Hypersensitivity—Acitretin—psoriasis	0.00055	0.0013	CcSEcCtD
Nepafenac—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.000548	0.0013	CcSEcCtD
Nepafenac—Vomiting—Calcitriol—psoriasis	0.000533	0.00126	CcSEcCtD
Nepafenac—Pruritus—Acitretin—psoriasis	0.000528	0.00125	CcSEcCtD
Nepafenac—Pruritus—Fluocinolone Acetonide—psoriasis	0.000526	0.00125	CcSEcCtD
Nepafenac—Headache—Calcitriol—psoriasis	0.000525	0.00124	CcSEcCtD
Nepafenac—Hypertension—Mycophenolic acid—psoriasis	0.000519	0.00123	CcSEcCtD
Nepafenac—Diabetes mellitus—Methotrexate—psoriasis	0.000513	0.00121	CcSEcCtD
Nepafenac—Eye disorder—Mycophenolate mofetil—psoriasis	0.000509	0.00121	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.000508	0.0012	CcSEcCtD
Nepafenac—Angiopathy—Cyclosporine—psoriasis	0.000507	0.0012	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000506	0.0012	CcSEcCtD
Nepafenac—Dry mouth—Mycophenolic acid—psoriasis	0.000501	0.00118	CcSEcCtD
Nepafenac—Nausea—Calcitriol—psoriasis	0.000498	0.00118	CcSEcCtD
Nepafenac—Angiopathy—Mycophenolate mofetil—psoriasis	0.000494	0.00117	CcSEcCtD
Nepafenac—Dizziness—Acitretin—psoriasis	0.000493	0.00117	CcSEcCtD
Nepafenac—Dizziness—Fluocinolone Acetonide—psoriasis	0.000492	0.00116	CcSEcCtD
Nepafenac—Nervous system disorder—Mycophenolic acid—psoriasis	0.000481	0.00114	CcSEcCtD
Nepafenac—Skin disorder—Mycophenolic acid—psoriasis	0.000477	0.00113	CcSEcCtD
Nepafenac—Vomiting—Acitretin—psoriasis	0.000474	0.00112	CcSEcCtD
Nepafenac—Vomiting—Fluocinolone Acetonide—psoriasis	0.000473	0.00112	CcSEcCtD
Nepafenac—Headache—Acitretin—psoriasis	0.000467	0.00111	CcSEcCtD
Nepafenac—Headache—Fluocinolone Acetonide—psoriasis	0.000466	0.0011	CcSEcCtD
Nepafenac—Eye disorder—Hydrocortisone—psoriasis	0.000464	0.0011	CcSEcCtD
Nepafenac—Vision blurred—Cyclosporine—psoriasis	0.000458	0.00108	CcSEcCtD
Nepafenac—Immune system disorder—Hydrocortisone—psoriasis	0.000448	0.00106	CcSEcCtD
Nepafenac—Nausea—Acitretin—psoriasis	0.000443	0.00105	CcSEcCtD
Nepafenac—Nausea—Fluocinolone Acetonide—psoriasis	0.000442	0.00105	CcSEcCtD
Nepafenac—Hypersensitivity—Hydroxyurea—psoriasis	0.000432	0.00102	CcSEcCtD
Nepafenac—PTGS2—Fluticasone Propionate—Dexamethasone—psoriasis	0.000429	0.0346	CbGdCrCtD
Nepafenac—PTGS2—Fluticasone Propionate—Betamethasone—psoriasis	0.000429	0.0346	CbGdCrCtD
Nepafenac—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000424	0.001	CcSEcCtD
Nepafenac—Hypertension—Cyclosporine—psoriasis	0.00042	0.000994	CcSEcCtD
Nepafenac—PTGS2—Fluticasone Propionate—Triamcinolone—psoriasis	0.000419	0.0338	CbGdCrCtD
Nepafenac—Vision blurred—Prednisolone—psoriasis	0.000417	0.000987	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.000411	0.000973	CcSEcCtD
Nepafenac—Hypertension—Mycophenolate mofetil—psoriasis	0.00041	0.000969	CcSEcCtD
Nepafenac—Dry mouth—Cyclosporine—psoriasis	0.000405	0.000958	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000401	0.000949	CcSEcCtD
Nepafenac—Eye disorder—Betamethasone—psoriasis	0.000396	0.000938	CcSEcCtD
Nepafenac—Eye disorder—Dexamethasone—psoriasis	0.000396	0.000938	CcSEcCtD
Nepafenac—Dry mouth—Mycophenolate mofetil—psoriasis	0.000395	0.000935	CcSEcCtD
Nepafenac—Nervous system disorder—Cyclosporine—psoriasis	0.000389	0.000921	CcSEcCtD
Nepafenac—Dizziness—Hydroxyurea—psoriasis	0.000387	0.000917	CcSEcCtD
Nepafenac—Skin disorder—Cyclosporine—psoriasis	0.000386	0.000913	CcSEcCtD
Nepafenac—Angiopathy—Dexamethasone—psoriasis	0.000385	0.000911	CcSEcCtD
Nepafenac—Angiopathy—Betamethasone—psoriasis	0.000385	0.000911	CcSEcCtD
Nepafenac—Hypertension—Prednisolone—psoriasis	0.000382	0.000904	CcSEcCtD
Nepafenac—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.00038	0.000899	CcSEcCtD
Nepafenac—Skin disorder—Mycophenolate mofetil—psoriasis	0.000376	0.00089	CcSEcCtD
Nepafenac—Hypertension—Hydrocortisone—psoriasis	0.000373	0.000883	CcSEcCtD
Nepafenac—Vomiting—Hydroxyurea—psoriasis	0.000372	0.000882	CcSEcCtD
Nepafenac—Headache—Hydroxyurea—psoriasis	0.000367	0.000869	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000365	0.000865	CcSEcCtD
Nepafenac—Hypertension—Triamcinolone—psoriasis	0.000351	0.000832	CcSEcCtD
Nepafenac—Nausea—Hydroxyurea—psoriasis	0.000348	0.000824	CcSEcCtD
Nepafenac—Pruritus—Mycophenolic acid—psoriasis	0.000347	0.000822	CcSEcCtD
Nepafenac—Nervous system disorder—Hydrocortisone—psoriasis	0.000346	0.000819	CcSEcCtD
Nepafenac—Eye disorder—Prednisone—psoriasis	0.000345	0.000817	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000343	0.000811	CcSEcCtD
Nepafenac—Skin disorder—Hydrocortisone—psoriasis	0.000343	0.000811	CcSEcCtD
Nepafenac—Dry mouth—Triamcinolone—psoriasis	0.000339	0.000802	CcSEcCtD
Nepafenac—Angiopathy—Prednisone—psoriasis	0.000335	0.000793	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000334	0.000791	CcSEcCtD
Nepafenac—Immune system disorder—Prednisone—psoriasis	0.000334	0.00079	CcSEcCtD
Nepafenac—Dizziness—Mycophenolic acid—psoriasis	0.000324	0.000768	CcSEcCtD
Nepafenac—Hypertension—Dexamethasone—psoriasis	0.000319	0.000755	CcSEcCtD
Nepafenac—Hypertension—Betamethasone—psoriasis	0.000319	0.000755	CcSEcCtD
Nepafenac—Vomiting—Mycophenolic acid—psoriasis	0.000312	0.000738	CcSEcCtD
Nepafenac—Headache—Mycophenolic acid—psoriasis	0.000307	0.000727	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000305	0.000721	CcSEcCtD
Nepafenac—Vision blurred—Prednisone—psoriasis	0.000303	0.000717	CcSEcCtD
Nepafenac—Nervous system disorder—Dexamethasone—psoriasis	0.000296	0.0007	CcSEcCtD
Nepafenac—Nervous system disorder—Betamethasone—psoriasis	0.000296	0.0007	CcSEcCtD
Nepafenac—Hypersensitivity—Cyclosporine—psoriasis	0.000292	0.000692	CcSEcCtD
Nepafenac—Nausea—Mycophenolic acid—psoriasis	0.000291	0.00069	CcSEcCtD
Nepafenac—Eye disorder—Methotrexate—psoriasis	0.000289	0.000683	CcSEcCtD
Nepafenac—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000285	0.000675	CcSEcCtD
Nepafenac—Pruritus—Cyclosporine—psoriasis	0.000281	0.000665	CcSEcCtD
Nepafenac—Angiopathy—Methotrexate—psoriasis	0.00028	0.000663	CcSEcCtD
Nepafenac—Immune system disorder—Methotrexate—psoriasis	0.000279	0.00066	CcSEcCtD
Nepafenac—Hypertension—Prednisone—psoriasis	0.000278	0.000657	CcSEcCtD
Nepafenac—Pruritus—Mycophenolate mofetil—psoriasis	0.000274	0.000648	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000272	0.000644	CcSEcCtD
Nepafenac—Hypersensitivity—Prednisolone—psoriasis	0.000266	0.00063	CcSEcCtD
Nepafenac—Dizziness—Cyclosporine—psoriasis	0.000262	0.000621	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Dexamethasone—psoriasis	0.00026	0.000616	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Betamethasone—psoriasis	0.00026	0.000616	CcSEcCtD
Nepafenac—Hypersensitivity—Hydrocortisone—psoriasis	0.00026	0.000615	CcSEcCtD
Nepafenac—Nervous system disorder—Prednisone—psoriasis	0.000257	0.000609	CcSEcCtD
Nepafenac—Dizziness—Mycophenolate mofetil—psoriasis	0.000256	0.000606	CcSEcCtD
Nepafenac—Skin disorder—Prednisone—psoriasis	0.000255	0.000603	CcSEcCtD
Nepafenac—Vision blurred—Methotrexate—psoriasis	0.000253	0.0006	CcSEcCtD
Nepafenac—Vomiting—Cyclosporine—psoriasis	0.000252	0.000597	CcSEcCtD
Nepafenac—Pruritus—Hydrocortisone—psoriasis	0.00025	0.000591	CcSEcCtD
Nepafenac—Headache—Cyclosporine—psoriasis	0.000249	0.000589	CcSEcCtD
Nepafenac—Vomiting—Mycophenolate mofetil—psoriasis	0.000246	0.000583	CcSEcCtD
Nepafenac—Hypersensitivity—Triamcinolone—psoriasis	0.000245	0.000579	CcSEcCtD
Nepafenac—Headache—Mycophenolate mofetil—psoriasis	0.000243	0.000574	CcSEcCtD
Nepafenac—Dizziness—Prednisolone—psoriasis	0.000239	0.000565	CcSEcCtD
Nepafenac—Nausea—Cyclosporine—psoriasis	0.000236	0.000558	CcSEcCtD
Nepafenac—Pruritus—Triamcinolone—psoriasis	0.000235	0.000556	CcSEcCtD
Nepafenac—Dizziness—Hydrocortisone—psoriasis	0.000233	0.000552	CcSEcCtD
Nepafenac—Nausea—Mycophenolate mofetil—psoriasis	0.00023	0.000544	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000227	0.000538	CcSEcCtD
Nepafenac—Headache—Prednisolone—psoriasis	0.000226	0.000536	CcSEcCtD
Nepafenac—Vomiting—Hydrocortisone—psoriasis	0.000224	0.000531	CcSEcCtD
Nepafenac—Headache—Hydrocortisone—psoriasis	0.000221	0.000523	CcSEcCtD
Nepafenac—Dizziness—Triamcinolone—psoriasis	0.00022	0.00052	CcSEcCtD
Nepafenac—Nervous system disorder—Methotrexate—psoriasis	0.000215	0.000509	CcSEcCtD
Nepafenac—Nausea—Prednisolone—psoriasis	0.000215	0.000508	CcSEcCtD
Nepafenac—Pruritus—Betamethasone—psoriasis	0.000213	0.000505	CcSEcCtD
Nepafenac—Pruritus—Dexamethasone—psoriasis	0.000213	0.000505	CcSEcCtD
Nepafenac—Skin disorder—Methotrexate—psoriasis	0.000213	0.000504	CcSEcCtD
Nepafenac—Vomiting—Triamcinolone—psoriasis	0.000211	0.0005	CcSEcCtD
Nepafenac—Nausea—Hydrocortisone—psoriasis	0.00021	0.000496	CcSEcCtD
Nepafenac—Headache—Triamcinolone—psoriasis	0.000208	0.000493	CcSEcCtD
Nepafenac—Dizziness—Dexamethasone—psoriasis	0.000199	0.000472	CcSEcCtD
Nepafenac—Dizziness—Betamethasone—psoriasis	0.000199	0.000472	CcSEcCtD
Nepafenac—Nausea—Triamcinolone—psoriasis	0.000197	0.000467	CcSEcCtD
Nepafenac—Hypersensitivity—Prednisone—psoriasis	0.000193	0.000458	CcSEcCtD
Nepafenac—Vomiting—Dexamethasone—psoriasis	0.000192	0.000454	CcSEcCtD
Nepafenac—Vomiting—Betamethasone—psoriasis	0.000192	0.000454	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Methotrexate—psoriasis	0.000189	0.000448	CcSEcCtD
Nepafenac—Headache—Dexamethasone—psoriasis	0.000189	0.000447	CcSEcCtD
Nepafenac—Headache—Betamethasone—psoriasis	0.000189	0.000447	CcSEcCtD
Nepafenac—Pruritus—Prednisone—psoriasis	0.000186	0.00044	CcSEcCtD
Nepafenac—Nausea—Betamethasone—psoriasis	0.000179	0.000424	CcSEcCtD
Nepafenac—Nausea—Dexamethasone—psoriasis	0.000179	0.000424	CcSEcCtD
Nepafenac—Dizziness—Prednisone—psoriasis	0.000174	0.000411	CcSEcCtD
Nepafenac—Vomiting—Prednisone—psoriasis	0.000167	0.000395	CcSEcCtD
Nepafenac—Headache—Prednisone—psoriasis	0.000164	0.000389	CcSEcCtD
Nepafenac—Hypersensitivity—Methotrexate—psoriasis	0.000162	0.000383	CcSEcCtD
Nepafenac—Nausea—Prednisone—psoriasis	0.000156	0.000369	CcSEcCtD
Nepafenac—Pruritus—Methotrexate—psoriasis	0.000155	0.000367	CcSEcCtD
Nepafenac—Dizziness—Methotrexate—psoriasis	0.000145	0.000343	CcSEcCtD
Nepafenac—Vomiting—Methotrexate—psoriasis	0.000139	0.00033	CcSEcCtD
Nepafenac—Headache—Methotrexate—psoriasis	0.000137	0.000325	CcSEcCtD
Nepafenac—Nausea—Methotrexate—psoriasis	0.00013	0.000308	CcSEcCtD
